ArthroCare develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes. Its devices improve many existing surgical procedures and enable new minimally invasive procedures. Many of ArthroCare’s devices use its internationally patented Coblation technology. This technology precisely dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology including its OPUS line of fixation products as well as re-usable surgical instruments. ArthroCare is leveraging these technologies in order to offer a comprehensive line of surgical devices to capitalize on a multi-billion dollar market opportunity across several surgical specialties, including its two core product areas consisting of Sports Medicine and Ear, Nose, and Throat as well as other areas such as spine, wound care, urology and gynecology. Millions of people undergo tissue surgery worldwide each year. ArthroCare’s Coblation technology offers an alternative to standard surgical techniques for removing and treating tissue. While most radiofrequency-based surgical products, such as lasers and electrosurgical devices, use imprecise, heat-driven processes to remove or cut tissue, ArthroCare’s Coblation-based devices operate at a lower temperature and are much more precise than traditional surgical tools. Instead of exploding tissue structures under high temperatures, Coblation technology gently dissolves target tissue, minimizing damage to surrounding healthy tissue. The significant benefits of ArthroCare’s Coblation technology have led to its adoption across a number of surgical specialties, including arthroscopy, spine and ENT, and research continues in new areas.